Abstract
The relation between sexual function and serum free testosterone (fT) levels, which represent the active fraction of circulating testosterone, was evaluated. Two groups of impotent male subjects with mild hypogonadism were treated with oral testosterone undecanoate (TU); these men presented with tT/luteinizing hormone (LH) ratio and tT levels at the lower limits of normal. The first group had serum fT below 6.6 ng/ml, considered the lower normal value, according to our laboratory method, whereas the second group had normal fT limits. Administration of TU improved sexual function only in impotent men with low fT levels, but not in subjects with normal fT levels, even though the tT levels and the tT/LH ratio of the two groups were not significantly different. The results of our study suggest the presence of a minimun serum fT threshold, lying near the lower normal range, which determines the male sexual function. Moreover, serum fT levels were a more sensitive index than tT for identifying impotent men who can be successfully treated with androgens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bancroft, J., and Wu, F. C. (1983). Changes in erectile responsiveness during androgen replacement therapy.Arch. Sex. Behav. 12: 59–66.
Brown, W. A., and Monti, P. M. (1978). Serum testosterone and sexual activity and interest in men.Arch. Sex. Behav. 7: 87–102.
Carani, C., Zini, D., Pachioni, C., Syed, B., Della Casa, L., and Marrama, P. (1987). Effects of prolonged oral administration of testosterone undecanoate on serum biologically active LH.J. Endocrinol. Invest. 10(Suppl. 1): 86.
Cooper, A. J. (1972). Diagnosis and management of endocrine impotence.Br. Med. J. 2: 34–36.
Davidson, J. M., Camargo, C. A., and Smith, E. R. (1979). Effects of androgen on sexual behavior in hypogonadal men.J. Clin. Endocrinol. Metab. 48: 955–958.
Davidson, J. M., Chen, J. J., Crapo, L., Gray, G. D., Greenleaf, W. J., and Catania, J. A. (1983). Hormonal changes and sexual function in aging men.J. Clin. Endocrinol. Metab. 57: 71–77.
Della Casa, L., Grandi, M., Carani, C., and Sighinolfi, R. (1983). Effects of oral testosterone undecanoate therapy in andrological pathology. In Crosignani, G. (ed.),Fertilità e Sterilità. Atti XII Congr. Soc. Ital. Fert. Steril. Milano, 1983 Monduzzi, Bologna, Italy, pp. 78–86.
Franchimont, P., Kicovic, P., Mattei, A., and Roulier, R. (1978). Effects of oral testosterone undecanoate in hypogonadal male patients.Clin. Endocrinol. 9: 313–320.
Griffin, J. E., and Wilson, J. D. (1985). Disorders of the testes and male reproductive tract. In Wilson, J. D., and Foster, D. W. (eds.),Williams' Textbook of Endocrinology W. B. Saunders, Philadelphia, pp. 259–310.
Lange, J. D., Brown, W. A., Wincze, J. P., and Zwick, W. (1980). Serum testosterone concentration and penile tumescence changes in men.Horm. Behav. 14: 267–270.
Luisi, M., and Franchi, F. (1980). Double blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.J. Endocrinol. Invest. 3: 305–308.
Maisey, N. M., Bingham, J., English, J., and Chokraborty, J. (1981). Clinical efficacy of testosterone undecanoate in male hypogonadism.Clin. Endocrinol. 14: 625–629.
O'Carrol, R., and Bancroft, J. (1984). Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study.Br. J. Psychiat. 145: 146–151.
Pirke, K. M., and Doerr, P. (1972). Age-related changes and interrelations between plasma testosterone, oestradiol and testosterone binding globulin in normal adult males.Acta Endocrinol. 74: 792–797.
Rubin, H., Henson, D., Falvo, R., and High, R. (1979). The relationship between men's endogenous levels of testosterone and their penile response to erotic stimuli.Behav. Res. Ther. 17: 305–312.
Salminies, P. Kockott, G., Pirke, K. M. Vogt, H. J., and Shill, W. B. (1982). Effects of testosterone replacement on sexual behavior in hypogonadal men.Arch. Sex. Behav. 11: 345–353.
Schiavi, R. C., and White, D. (1976). Androgen and male sexual function: a review of human studies.J. Sex Marital Ther. 2: 214–228.
Skakkebaeck, N., Bancroft, J., Davidson, D., and Warner, P. (1981). Androgen replacement with oral testosterone undecanoate in hypogonadal men: A double blind controlled study.Clin. Endocrinol. 14: 49–61.
Tsitouras, P. O., Martin, C. E., and Harman, S. M. (1982). Relationship of serum testosterone to sexual activity in healthy elderly men.J. Gerontol. 36: 288–293.
Vlahos, J., MacMahon, W., Sgoutas, D., Bowers, W., Thompson, J., and Trawick, W. (1982). An improved ultrafiltration method for determing free testosterone in serum.Clin. Chem. 28: 2286–2289.
Ward, I. L. (1977). Regulation of sexual behavior by hormone in male non-primates. In Moneyn, J., and Musaph, H. (eds.),Handbook of Sexology, Excerpta Medica, Amsterdam, The Netherlands, pp. 377–392.
Wu, F. C., Bancroft, J., Davidson, W. U., and Nicol, K. (1982). The behavioral effects of testosterone undercanoate in adult Klinefelter men: A controlled study.Clin. Endocrinol. 16: 489–497.
Zini, D., Carani, C., Della Casa, L., Baldini, A., Piccinini, D., and Marrama, P. (1985). Sexual and endocrine effects of testosterone undecanoate administration in impotent men with mild hypogonadism. In Kothari, P. (ed. and pub.),Sexuality in a Changing World. Proceedings of the 7th World Congress of Sexology, New Delhi, India, pp. 145–150.
Zini, D., Carani, C., Baldini, A., Cavicchioli, C., Piccinini, D., and Marrama, P. (1986). Further acquisitions on gonadal function in bromocriptine treated hyperprolactinemic male patients.Pharm. Res. Commun. 18: 601–610.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carani, C., Zini, D., Baldini, A. et al. Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Arch Sex Behav 19, 223–234 (1990). https://doi.org/10.1007/BF01541548
Issue Date:
DOI: https://doi.org/10.1007/BF01541548